October 10, 2008
Michael Kane, M.D. To Present At American College of Rheumatology Annual Scientific Meeting
D2Hawkeye(R), Inc., the market leader in transforming healthcare data into valuable information for managing clinical risk and costs, announced today that Michael Kane, M.D., D2Hawkeye Consultant, will be presenting at the American College of Rheumatology/Association of Rheumatology Health Professionals Scientific Meeting 08, on October 24-29, 2008 in San Francisco, CA. The six-day educational program will include workshops, study groups, abstract/research sessions, as well as pre-conference courses.
Dr. Kane will present a study, titled "Genetic Testing for Rituximab Responsiveness," in which D2Hawkeye's aggregate research database was used to examine the health benefits and costs of using pharmacogenetic testing to guide treatment decisions for patients with rheumatoid arthritis who have failed therapy with other disease modifying anti-rheumatic drugs.
D2Hawkeye (D2) is the market leader for healthcare data service solutions including data mining, decision support, clinical quality analysis, and risk analysis tools. D2 builds and manages fully-integrated medical and financial databases, applying proprietary evidence-based medical rules, and provides an intuitive, easy-to-use, ASP-based interface for medical analytics and reporting. D2's tools are used by industry professionals to estimate cost and risk trends identify emerging high-risk consumers for optimal allocation of medical management resources and interventions, and compare performance against industry benchmarks. D2 also provides medical advisory, medical analytics, benchmarking, and other business services on an outsourced basis. For more information, please visit www.d2hawkeye.com.
About the American College of Rheumatology
The American College of Rheumatology is an organization of and for physicians, health professionals, and scientists that advances rheumatology through programs of education, research, advocacy and practice support that foster excellence in the care of people with arthritis and rheumatic and musculoskeletal diseases.